Is diabetes a risk factor in fungal infections? Diabetes and fungal infections

Rabiye Altınbaş

doi:10.5281/zenodo.15032404

Authors

Rabiye Altınbaş Dr. Ersin Arslan Training and Research Hospital, Department of Medical Microbiology, Gaziantep, Turkey https://orcid.org/0000-0003-2535-0480

DOI:

https://doi.org/10.5281/zenodo.15032404

Keywords:

Diabetes, fungal infections, mucormycosis

Abstract

Diabetes is a metabolic disease characterized by abnormally high blood glucose levels and associated with complications. In diabetes, with dysregulation and the loss of functions of immune system cells, phagocytic activity, which is necessary to control and kill pathogens and process them for antigen presentation, is reduced. Thus, individuals with diabetes are more prone to infections and more susceptible to certain complications related to infections. Diabetic patients are particularly susceptible to fungal infections because their vascular and immunological systems are compromised. Many different types of fungal infections occur in people with diabetes, but one type with a particularly serious risk of death is mucormycosis. To obtain successful results from combined antifungal treatment and surgical interventions, it is necessary to address the underlying predisposing factors.

References

Erener S. Diabetes, infection risk and COVID-19. Mol Metab. 2020;39:101044.

Ekeng BE, Kibone W, Itam-Eyo AE, Bongomin F. Onychomycosis in Patients with Diabetes Mellitus in Africa: A Global Scoping Review, 2000-2021. Mycopathologia. 2023;188:173–82.

Bielka W, Przezak A, Pawlik A. The Role of the Gut Microbiota in the Pathogenesis of Diabetes. Int J Mol Sci. 2022;23:480.

Vavreckova M, Galanova N, Kostovcik M, Krystynik O, Ivanovova E, Roubalova R, et al. Specific gut bacterial and fungal microbiota pattern in the first half of pregnancy is linked to the development of gestational diabetes mellitus in the cohort including obese women. Front Endocrinol (Lausanne). 2022;13:1–13.

Morales-Franco B, Nava-Villalba M, Medina-Guerrero EO, Sánchez-Nuño YA, Davila-Villa P, Anaya-Ambriz EJ, et al. Host-Pathogen Molecular Factors Contribute to the Pathogenesis of Rhizopus spp. in Diabetes Mellitus. Curr Trop Med Rep. 2021;8:6-17.

Hussain A, Bhowmik B, Cristina do VMN. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract. 2020;162:108142.

Gregorczyk-Maga I, Fiema M, Kania M, Jachowicz-Matczak E, Romaniszyn D, Gerreth K, et al. Oral Microbiota-One Habitat or Diverse Niches? A Pilot Study of Sampling and Identification of Oral Bacterial and Fungal Biota in Patients with Type I Diabetes Mellitus Treated with Insulin Pump. Int J Environ Res Public Health. 2023;20:2252.

Yildiz F, Toraman ZA. Diyabetli Hastalarda Yüzeyel Mantar Enfeksiyon Etkeni Olarak Saptanan Dermatofit ve Mayaların Tiplendirilmesi, Mayaların Antifungal Duyarlılıklarının Belirlenmesi. F. Ü. Sağ. Bil. Tıp.Derg. 2020;34:41–7.

American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care. 2018;41:917–28.

Lao M, Li C, Li J, Chen D, Ding M, Gong Y. Opportunistic invasive fungal disease in patients with type 2 diabetes mellitus from Southern China: Clinical features and associated factors. J Diabetes Investig. 2020;11:731-44.

Khoshbayan A, Didehdar M, Chegini Z, Taheri F, Shariati A. A closer look at pathogenesis of cerebral mucormycosis in diabetic condition: A mini review. J Basic Microbiol. 2021;61:212-8.

Lax C, Pérez-Arques C, Navarro-Mendoza MI, Cánovas-Márquez JT, Tahiri G, Pérez-Ruiz JA, et al. Genes, Pathways and Mechanisms Involved in the Virulence of Mucorales. Genes (Basel). 2020;11:317.

Steinbrink JM, Miceli MH. Clinical Review of Mucormycosis. Infect Dis Clin North Am. 2021;35:435-52.

Abuhajar E, Ali K, Zulfiqar G, Ansari K Al, Raja HZ, Bishti S, et al. Management of Chronic Atrophic Candidiasis (Denture Stomatitis)-A Narrative Review. Int J Environ Res Public Health. 2023;20:3029.

Jafarzadeh J, Tavakoli M, Zabihzadeh A, Omran SM, Bayani M, Javanian M, et al. Rhino-Orbital Mucormycosis in Patients with Diabetes Infected with COVID-19 in Babol, Iran: Report of Six Cases. Annals of Clinical Case Reports. 2023;8:1–5.

Sampath A, Weerasekera M, Dilhari A, Gunasekara C, Bulugahapitiya U, Fernando N, et al. Type 2 diabetes mellitus and oral Candida colonization: Analysis of risk factors in a Sri Lankan cohort. Acta Odontol Scand. 2019;77:508–16.

Ozawa K, Takai M, Taniguchi T, Kawase M, Takeuchi S, Kawase K, et al. Diabetes Mellitus as a Predictive Factor for Urinary Tract Infection for Patients Treated with Kidney Transplantation. Medicina (Kaunas). 2022;58:1488.

Guidelines I. Practical guidelines on the prevention and management of disease IWGDF 2023 update. 2023.

Navarro-Pérez D, Tardáguila-García A, García-Oreja S, López-Moral M, García-Madrid M, Lázaro-Martínez JL. Onychomycosis associated with diabetic foot syndrome: A systematic review. Mycoses. 2023;66:459–66.

Fávero MLD, Bonetti AF, Domingos EL, Tonin FS, Pontarolo R. Oral antifungal therapies for toenail onychomycosis: a systematic review with network meta-analysis toenail mycosis: network meta-analysis. J Dermatolog Treat. 2022;33:121–30.

Foley K, Gupta AK, Versteeg S, Mays R, Villanueva E, John D. Topical and device-based treatments for fungal infections of the toenails. Cochrane Database Syst Rev. 2020;1:CD012093.

Oz Y, Qoraan I, Oz A, Balta I. Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey. Int J Dermatol. 2017;56:68-74.

Kung VM, Ferraz C, Kennis M, Franco-Paredes C, Tuells J, Barahona LV, et al. Diabetes Mellitus Type 2 as a Risk Factor and Outcome Modifier for Cryptococcosis in HIV Negative, Non‑transplant Patients, a Propensity Score Match Analysis. Curr Microbiol. 2023;80:396.

Howard-Jones AR, Sparks R, Pham D, Halliday C, Beardsley J, Chen SCA. Pulmonary Cryptococcosis. J Fungi. 2022;8:1156.

Nsenga L, Kajjimu J, Olum R, Ninsiima S, Kyazze AP, Ssekamatte P, et al. Cryptococcosis complicating diabetes mellitus. Ther Adv Infect Dis. 2021;8:20499361211014769.

Archuleta S, Gharamti AA, Sillau S, Castellanos P, Chadalawada S, Mundo W, et al. Increased mortality associated with uncontrolled diabetes mellitus in patients with pulmonary cryptococcosis: a single US cohort study. Ther Adv Infect Dis. 2021;8:20499361211004367.

Jafarzadeh L, Ranjbar M, Nazari T, Eshkaleti MN, Gharehbolagh SA, Sobel JD, et al. Vulvovaginal candidiasis: An overview of mycological, clinical and immunological aspects. J Obstet Gynaecol Res. 2022;48:1546–60.

Mosca V, Arita GS, Vilegas LV, Faria DR, Sakita KM, Vendramini FA. et al. Vulvovaginal candidiasis in a murine model of diabetes emphasizing the invasive ability of etiological agents. Future Microbiol. 2020;15:1001–13.

Fernández-Trujillo L, Eraso I, Morales EI, Sua LF. Invasive Aspergillosis in a Patient With Diabetes Mellitus as the Only Risk Factor: Case Report and Literature Review. J Investig Med High Impact Case Rep. 2023;11:23247096231175443.

Chen X, Sun J, Chen YF, Wang J, Liu SY. Pneumonia caused by Schizophyllum commune in a patient with diabetes. Medicine (Baltimore). 2023;102:e33773.

Dan J, Zhou Q, Zhai H, Cheng J, Wan L, Ge C, et al. Clinical analysis of fungal keratitis in patients with and without diabetes. PLoS One. 2018;13:e0196741.

Chegini Z, Didehdar M, Khoshbayan A, Rajaeih S, Salehi M, Shariati A. Mucormycosis in Diabetic Patients: A Systematic Review of Case. Mycoses. 2020;63:1264-82.

Mahalaxmi I, Jayaramayya K, Venkatesan D, Subramaniam MD, Renu K, Vijayakumar P. Mucormycosis: An opportunistic pathogen during COVID-19. Environ Res. 2021;201:111643.

Reid G, Iii JPL, Fishbein MC, Clark NM. Mucormycosis. Semin Respir Crit Care Med. 2020;41:99–114.

Karat S, Lobo AC, Satish D, Devaraj R, Manjooran RR, Nithyanandam S. Uncontrolled diabetes mellitus exacerbated by COVID‑19 – induced inflammation is the risk factor for COVID‑19 – associated rhino‑orbito‑cerebral mucormycosis: A matched pair case – control study. Indian J Ophthalmol. 2022;70:3096-101.

Ryu BU, Laylani NAR, Siliezar PD, Lee AG. Rhino-orbital mucormycosis. Curr OpinOphthalmol. 2022;33:501-6.

Allaq AA, Kamoka HME, Sidik NJ, Abdul-Aziz A, Abdulrazzaq AI, Agha HM, et al. The link between black fungus and Covid-19 disease in diabetes mellitus patients. Biomedical Research and Therapy. 2021;8:4689-94.